Bruining, J.

diabetes patient insulin mutation study children sulfonylurea type 1 diabetes treatment mica *a month control kir 6.2 mutations haplotype transfer 6.2 association effect syndrome table group diabetes mellitus allele kir 6.2 patients monogenic diabetes feature hattersley diagnosis disease subcutaneous insulin infusion phase meta-analysi mellitu cause glucose monogenic parent hba 1c type 2 diabetes 1 patients signi impact analysis score result channel 1 mutations quality family class dq 8dr haplotypes factor ashcroft fm pedsql comparison population ellard glycemic control range 3.5 months signi ficantly sanjeevi sulphonylurea therapy genet sulfonylurea therapy pearson run-in phase glyburide randomized pancreatic hospital receptor insulin resistance insulin secretion level ficant group b glycaemic control frequency